Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans

被引:67
作者
Ha, KC
White, TC
机构
[1] Seattle Biomed Res Inst, Seattle, WA 98109 USA
[2] Univ Washington, Sch Publ Hlth & Community Med, Dept Pathobiol, Seattle, WA 98195 USA
关键词
D O I
10.1128/AAC.43.4.763
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Oral infections caused by the yeast Candida albicans are some of the most frequent and earliest opportunistic infections in human immunodeficiency virus-infected patients. The widespread use of azole antifungal drugs has led to the development of drug resistance, creating a major problem in the treatment of yeast infections in AIDS patients and other immunocompromised individuals. Several molecular mechanisms that contribute to drug resistance have been identified. In C. albicans, the ability to morphologically switch from yeast cells (blastospores) to filamentous forms (hyphae) is an important virulence factor which contributes to the dissemination of Candida in host tissues and which promotes infection and invasion. A positive correlation between the level of antifungal drug resistance and the ability to form hyphae in the presence of azole drugs has been identified. Under hypha-inducing conditions in the presence of an azole drug, resistant clinical isolates form hyphae, while susceptible yeast isolates do not. This correlation is observed in a random sample from a population of susceptible and resistant isolates and is independent of the mechanisms of resistance. S-35-methionine incorporation suggests that growth inhibition is not sufficient to explain the inhibition of hyphal formation, but it may contribute to this inhibition.
引用
收藏
页码:763 / 768
页数:6
相关论文
共 33 条
[1]   Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance [J].
Albertson, GD ;
Niimi, M ;
Cannon, RD ;
Jenkinson, HF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2835-2841
[2]  
BORGERS M, 1989, MYCOSES, V1, P53
[3]   PUTATIVE VIRULENCE FACTORS OF CANDIDA-ALBICANS [J].
CUTLER, JE .
ANNUAL REVIEW OF MICROBIOLOGY, 1991, 45 :187-218
[4]  
GALGIANI J, 1992, REFERENCE METHOD BRO, V12
[5]   REDUCED AZOLE SUSCEPTIBILITY OF ORAL ISOLATES OF CANDIDA-ALBICANS FROM HIV-POSITIVE PATIENTS AND A DERIVATIVE EXHIBITING COLONY MORPHOLOGY VARIATION [J].
GALLAGHER, PJ ;
BENNETT, DE ;
HENMAN, MC ;
RUSSELL, RJ ;
FLINT, SR ;
SHANLEY, DB ;
COLEMAN, DC .
JOURNAL OF GENERAL MICROBIOLOGY, 1992, 138 :1901-1911
[6]  
GREENSPAN D, 1990, AIDS MOUTH, P91
[7]  
HA KC, UNPUB
[9]   EFFECT OF IMIDAZOLE ANTIFUNGALS ON THE DEVELOPMENT OF GERM TUBES BY STRAINS OF CANDIDA-ALBICANS [J].
JOHNSON, EM ;
RICHARDSON, MD ;
WARNOCK, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 (04) :303-316
[10]   INVITRO RESISTANCE TO IMIDAZOLE ANTIFUNGALS IN CANDIDA-ALBICANS [J].
JOHNSON, EM ;
RICHARDSON, MD ;
WARNOCK, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (06) :547-558